956
Views
13
CrossRef citations to date
0
Altmetric
Laboratory Study

Oxidative Stress in 5/6 Nephrectomized Rat Model: Effect of Alpha-Lipoic Acid

, , , , &
Pages 907-914 | Received 18 Feb 2012, Accepted 29 Apr 2012, Published online: 11 Jun 2012

REFERENCES

  • Rodrı´guez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ. The role of immunocompetent cells in non-immune renal diseases. Kidney Int. 2001;59:1626–1640.
  • Miller III ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46.
  • Reed LJ. A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes. J Biol Chem. 2001;276:38329–38336.
  • Tastekin N, Aydogdu N, Dokmeci D, . Protective effects of L-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol Res. 2007;56:303–310.
  • Bilska A, Wodek L. Lipoic acid – the drug of the future? Pharmacol Rep. 2005;57:570–577.
  • Özler M, Ersöz N, Özerhan İH, Topal T, Öter Ş, Korkmaz A. The effect of alpha-lipoic acid in the prevention of peritoneal adhesions. Turk J Gastroenterol. 2011;22:190–194.
  • Tunc T, Oter S, Güven A, . Protective effect of sulfhydryl-containing antioxidants against ischemia/reperfusion injury of prepubertal rat intestine. J Gastroenterol Hepatol. 2009;24: 681–687.
  • Guven A, Tunc T, Topal T, . Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine. Surg Today. 2008;38:1029–1035.
  • Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic Acid. Front Pharmacol. 2011;2:69.
  • Melhem MF, Craven PA, Liachenko J, DeRubertis FR. Alphalipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol. 2002;13:108–116.
  • Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int. 2005;67:1371–1380.
  • Tain YL, Freshour G, Dikalova A, Griendling K, Baylis C. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol. 2007;292:F1404–F1410.
  • Lateef H, Aslam MN, Stevens MJ, Varani J. Pretreatment of diabetic rats with lipoic acid improves healing of subsequently-induced abrasion wounds. Arch Dermatol Res. 2005;297:75–83.
  • Tanaka T, Kojima I, Ohse T, . Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest. 2005;85:1292–1307.
  • Jiang SH, Liu CF, Zhang XL, . Renal protection by delayed ischemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation. Cell Biochem Funct. 2007;25:335–343.
  • Budisavljevic MN, Hodge L, Barber K, Fulmer JR, Durazo-Arvizu RA, Self SE. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am J Physiol Renal Physiol. 2003;285:F1138–F1148.
  • Quiroz Y, Ferrebuz A, Romero F, Vaziri ND, Rodriguez-Iturbe B. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am J Physiol Renal Physiol. 2008;294:F336–F344.
  • Podjarny E, Hasdan G, Bernheim J, . Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats. Nephrol Dial Transplant. 2004;19:2223–2227.
  • Anjaneyulu M, Chopra K. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney. Am J Nephrol. 2004;24:488–496.
  • Alican I, Kaçmaz A, Sakarcan A, Sener G, Paskaloğlu K, Satiroglu H. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol. 2004;43:698–705.
  • Sehirli O, Sener E, Cetinel S, Yuksel M, Gedik N, Sener G. Alpha-lipoic acid protects against renal ischemia-reperfusion injury in rats. Clin Exp Pharmacol Physiol. 2008;35:249–255.
  • Celik I, Cihangiroglu M, Ilhan N, Akpolat N, Akbulut HH. Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity. Basic Clin Pharmacol Toxicol. 2005;97:325–332.
  • El-Beshbishy HA, Bahashwan SA, Aly HA, Fakher HA. Abrogation of cisplatin-induced nephrotoxicity in mice by alpha lipoic acid through ameliorating oxidative stress and enhancing gene expression of antioxidant enzymes. Eur J Pharmacol. 2011;668:278–284.
  • Lee YM, Bae SY, Won NH, Pyo HJ, Kwon YJ. Alpha-lipoic acid attenuates cisplatin-induced tubulointerstitial injuries through inhibition of mitochondrial bax translocation in rats. Nephron Exp Nephrol. 2009;113:e104–e112.
  • Kang KP, Kim DH, Jung YJ, . Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. Nephrol Dial Transplant. 2009;24: 3012–3020.
  • Bae EH, Lee KS, Lee J, . Effects of alpha-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats. Am J Physiol Renal Physiol. 2008;294:F272–F280.
  • Amudha G, Josephine A, Sudhahar V, Varalakshmi P. Protective effect of lipoic acid on oxidative and peroxidative damage in cyclosporine A-induced renal toxicity. Int Immunopharmacol. 2007;7:1442–1449.
  • Vaziri ND, Dicus M, Ho N, Sindhu R. Oxidative stress and dysregulation of superoxide dismutase and NAD(P)H oxidase in renal insufficiency. Kidney Int. 2003;63:179–185.
  • Quiroz Y, Ferrebuz A, Vaziri ND, Rodriguez-Iturbe B. Effect of chronic antioxidant therapy with superoxide dismutase-mimetic drug, tempol, on progression of renal disease in rats with renal mass reduction. Nephron Exp Nephrol. 2009;112:e31–e42.
  • Van den Branden C, Verelst R, Vamecq J, Vanden Houte K, Verbeelen D. Effect of vitamin E on antioxidant enzymes, lipid peroxidation products and glomerulosclerosis in the rat remnant kidney. Nephron. 1997;76:77–81.
  • Hahn S, Krieg Jr RJ, Hisano S, . Vitamin E suppresses oxidative stress and glomerulosclerosis in rat remnant kidney. Pediatr Nephrol. 1999;13:195–198.
  • Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem. 2004;11:1135–1146.
  • Changchun C, Xiaoqiang D, Zhouluo O, Peng L, Jianzhou Z. In vivo transfection of NF-kappa B decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int. 2004;65:834–845.
  • Tylicki L, Rutkowski B, Hörl WH. Antioxidants: A possible role in kidney protection. Kidney Blood Press Res. 2003;26:303–314.
  • Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int. 1998;53:1748–1754.
  • Vasdev S, Gill VD, Parai S, Gadag V. Effect of moderately high dietary salt and lipoic acid on blood pressure in Wistar-Kyoto rats. Exp Clin Cardiol. 2007;12:77–81.
  • Louhelainen M, Merasto S, Finckenberg P, Lapatto R, Cheng ZJ, Mervaala EM. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. J Hypertens. 2006;24:947–956.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.